13/12/2025
Obesity is a chronic, relapsing disease — not a failure of willpower.
Newer injectable therapies (such as GLP-1–based treatments) have changed how we manage obesity by targeting appetite regulation, insulin resistance, and metabolic health.
These medications are not shortcuts and are not for everyone. When used appropriately, they work best alongside lifestyle modification, nutrition, physical activity, and long-term follow-up.